Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
about
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastimDrug delivery systems and combination therapy by using vinca alkaloidsInfection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practiceClinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor AnalysisEffects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer PatientsResults of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy.The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis.Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast CancerExternal validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma.Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin's lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy.Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma.Cancer in liver transplant recipients: management and outcomes.
P2860
Q26738509-3175FC19-A37A-465D-B0C4-D1D46D669F05Q28829009-4D0B7D67-117B-4184-BD0B-9310A5D1275EQ33861071-34B561E8-0066-461E-8CBA-3A66FCEC7C53Q34390036-6389E25D-74FB-4F73-A3A6-A42A386BC996Q35862322-6ADF0797-619D-48C2-83FB-C203C58DAD94Q35996084-09BE6445-FD00-4892-A140-735ABE932D49Q36885665-09CC0450-C71B-473D-A25A-E2A7AC728FE8Q38983276-1AD6AE8B-4FCD-490F-90BF-82907495E186Q40163155-3E9D1EAA-8016-4828-AEBB-C12F72146472Q40410427-1A050B2A-918F-4E26-93C2-59780351C2D4Q41684418-AEDCC752-BCBB-4982-B7F4-41F9FFA368D4Q44569718-36001A48-01C0-48B9-9ACA-FA391DE4BC0BQ45902611-7F988CF7-D0B9-4DAA-89CC-6CCA633259B5Q48808489-1D2AB900-DB49-439D-807E-713634AAF3B5Q51339494-BBF044EF-D50B-491F-9B2F-E58E4FFCB9CDQ51556801-7E1098BD-A8E2-4E59-8CAC-EF160DC621E0Q54187954-8B891ADB-0013-485E-9028-0E37BFA6C7CA
P2860
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@ast
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@en
type
label
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@ast
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@en
prefLabel
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@ast
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P1476
Impact of febrile neutropenia ...... diffuse large B-cell lymphoma
@en
P2093
Antonio Salar Silvestre
Francesca G Rossi
Kate Bendall
Pieternella J Lugtenburg
Ruth Pettengell
Ulrich Dührsen
Ulrich Jaeger
Zsolt Szabo
P2860
P2888
P304
P356
10.1007/S00520-011-1306-6
P577
2011-11-20T00:00:00Z